[Acilact and improvement of the health status of sickly children]

M S Bliakher; I M Fedorova; T K Lopatina; S N Arkhipov; I V Kapustin; Z K Ramazanova; N V Karpova; V A Ivanov; N V Sharapov

[Acilact and improvement of the health status of sickly children]

Vestn Ross Akad Med Nauk. 2005:(12):32-5.

[Article in Russian]

Authors

M S Bliakher, I M Fedorova, T K Lopatina, S N Arkhipov, I V Kapustin, Z K Ramazanova, N V Karpova, V A Ivanov, N V Sharapov

PMID: 16404981

Abstract

A complex study of the effects of Acilact on the immune and interferon status, phagocyte defense, and cytokine balance in sickly children showed that Acilact had a positive effect on the immune system in these patients. The preparation is able to normalize abnormal immune parameters, and does not influence healthy immune system. In some ways Acilact has advantages over IRS 19 vaccine. Simultaneous administration of these two preparations is appropriate in some cases.

Publication types

Controlled Clinical Trial
English Abstract

MeSH terms

Antigens, CD / drug effects
Antigens, CD / immunology
Bacterial Vaccines / pharmacology
Bacterial Vaccines / therapeutic use
Biological Products / pharmacology*
Biological Products / therapeutic use*
Child
Child, Preschool
Ecology
Health Status*
Humans
Lactobacillus acidophilus
Probiotics / therapeutic use
Respiratory Tract Infections / epidemiology
Respiratory Tract Infections / prevention & control

Substances

Antigens, CD
Bacterial Vaccines
Biological Products
IRS 19 vaccine
acilact